Asthma D001249

Related MeSH Hierarchy (4)

Diseases [C] » Respiratory Tract Diseases [C08] » Bronchial Diseases » Asthma

Diseases [C] » Respiratory Tract Diseases [C08] » Respiratory Hypersensitivity » Asthma

Description

A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).   MeSH

Subtype Terms (5)

Asthma, Exercise-Induced
17 drugs (13 approved, 4 experimental)

Asthma, Occupational
1 experimental drug

Status Asthmaticus
18 drugs (17 approved, 1 experimental)


Phase 4 Indicated Drugs (80)

Phase 2 Indicated Drugs (209)

Key: D001249 (208) Subtype (1)


Organization Involved with Phase 4 Indications (180)

Key: D001249 (177) Subtype (3)

Organization Involved with Phase 3 Indications (106)

Key: D001249 (104) Subtype (2)

Organization Involved with Phase 2 Indications (131)

Key: D001249 (129) Subtype (2)

Organization Involved with Other Experimental Indications (56)

Key: D001249 (54) Subtype (2)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.